Plus Therapeutics, Inc.
PSTV
$0.5424
-$0.0855-13.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.03M | -27.12M | -12.98M | -12.89M | -13.23M |
| Total Depreciation and Amortization | 558.00K | 651.00K | 660.00K | 622.00K | 578.00K |
| Total Amortization of Deferred Charges | 0.00 | 4.00K | 20.00K | 50.00K | 91.00K |
| Total Other Non-Cash Items | 5.33M | 10.87M | -1.48M | -1.44M | -331.00K |
| Change in Net Operating Assets | -3.72M | 3.39M | 3.22M | 2.43M | 2.95M |
| Cash from Operations | -16.86M | -12.21M | -10.55M | -11.22M | -9.94M |
| Capital Expenditure | -35.00K | -109.00K | -146.00K | -177.00K | -173.00K |
| Sale of Property, Plant, and Equipment | 30.00K | 30.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.01M | -110.00K | -3.97M | -4.04M | -4.05M |
| Cash from Investing | -1.02M | -189.00K | -4.11M | -4.22M | -4.22M |
| Total Debt Issued | 3.74M | 7.03M | 3.29M | 3.29M | 3.29M |
| Total Debt Repaid | -7.00M | -10.59M | -4.00M | -4.40M | -4.80M |
| Issuance of Common Stock | 18.68M | 22.97M | 7.31M | 7.46M | 10.58M |
| Repurchase of Common Stock | 0.00 | 0.00 | -374.00K | -500.00K | -500.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -220.00K | -45.00K | -45.00K | -193.00K | -393.00K |
| Cash from Financing | 15.20M | 19.37M | 6.19M | 5.66M | 8.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.68M | 6.97M | -8.48M | -9.78M | -5.98M |